Trilogy Capital’s iShares MSCI Intl Quality Factor ETF IQLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.96M Sell
39,653
-180
-0.5% -$8.8K 0.08% 158
2026
Q1
$1.84M Sell
39,833
-3,377
-8% -$160K 0.08% 150
2025
Q4
$1.96M Sell
43,210
-2,678
-6% -$120K 0.09% 147
2025
Q3
$2.03M Sell
45,888
-5,513
-11% -$238K 0.09% 148
2025
Q2
$2.22M Sell
51,401
-13,220
-20% -$549K 0.11% 141
2025
Q1
$2.56M Sell
64,621
-264,401
-80% -$10.4M 0.13% 113
2024
Q4
$12.2M Buy
329,022
+1,626
+0.5% +$63.6K 0.63% 44
2024
Q3
$13.6M Buy
327,396
+11,298
+4% +$450K 0.68% 41
2024
Q2
$12.3M Buy
+316,098
New +$12.4M 0.67% 45

Other funds holding IQLT

Trilogy Capital's IQLT Position: Q2 2026 in Review

Trilogy Capital reduced its iShares MSCI Intl Quality Factor ETF (IQLT) stake by 0.45% in Q2 2026, selling an estimated $8.8K and leaving 39,653 shares worth $1.96M. The position accounts for 0.08% of the portfolio, ranked #158.

Trilogy Capital first reported a position in IQLT in Q2 2024 and has held it in 9 quarters since. The position peaked at $13.6M in Q3 2024. 136 funds tracked by Wall St. Rank hold IQLT as of Q2 2026.

  • Trilogy Capital held 39,653 shares of iShares MSCI Intl Quality Factor ETF worth $1.96M as of Q2 2026.
  • Trilogy Capital sold 180 iShares MSCI Intl Quality Factor ETF shares in Q2 2026, an estimated $8.8K.
  • iShares MSCI Intl Quality Factor ETF made up 0.08% of Trilogy Capital's portfolio in Q2 2026, its #158 holding.
  • Trilogy Capital first reported a position in iShares MSCI Intl Quality Factor ETF in Q2 2024 and has held it in 9 quarters since.
  • Trilogy Capital's iShares MSCI Intl Quality Factor ETF position peaked at $13.6M in Q3 2024.
  • 136 funds tracked by Wall St. Rank held iShares MSCI Intl Quality Factor ETF as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.